VX-407

N/A

Report date: 2026/05/14 20:00:28
NMEFirst In Class

Base Information

Drug NameVX-407
Drug Alias NameVX-407
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPolycystin-1 gene transference
TargetsPolycystin-1
Therapy Area/IndicationsPolycystic Kidney, Autosomal Dominant
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumCanadaUnited States +[8] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesVertex Pharmaceuticals Incorporated
China Registration ClassN/A

Develop Information

Active CompaniesVertex Pharmaceuticals Incorporated
Inactive CompaniesN/A
Active IndicationsPolycystic Kidney, Autosomal Dominant
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A